US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Global Breast Pump Market Report 2016
8/20/2016 | published by: 9Dimen Research
... and the main countries (United States, Germany, Japan and China). The report firstly introduced the Breast Pump basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures ...  |  read more...
USD 2,850
Dysmenorrhea  - Market Insights, Epidemiology and Market Forecast-2023
9/1/2016 | published by: DelveInsight
... Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Dysmenorrhea forecasted market share for ten years to 2023 segmented by seven major markets. In addition, ...  |  read more...
USD 4,950
Global Infertility Partnering 2010 to 2016
9/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Menopause Partnering 2010-2016
9/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Sexual Dysfunction Partnering 2010 to 2016
9/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Breast Cancer: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ...  |  read more...
USD 14,250
Global Ovarian Cancer Partnering 2010 to 2016
9/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Human Papilloma Virus Partnering 2010 to 2016
9/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Ovarian Cancer: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ...  |  read more...
USD 14,250
Post Menopausal Osteoporosis - Market Insights, Epidemiology and Market Forecast-2023
9/1/2016 | published by: DelveInsight
... (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Post Menopausal Osteoporosis forecasted market share for ten years to 2023 segmented by seven ...  |  read more...
USD 4,950
Global Breast Cancer Partnering 2010 to 2016
9/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Cervical Cancer Partnering 2010 to 2016
9/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Contraceptives Market Report 2016
8/20/2016 | published by: 9Dimen Research
... main countries (United States, Germany, Japan and China). The report firstly introduced the Contraceptives basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. ...  |  read more...
USD 2,850
Global and Chinese Artificial Insemination Catheter Industry, 2016 Market Research Report
8/1/2016 | published by: Prof-Research
... the Chinese market. The report provides key statistics on the market status of the Artificial Insemination Catheter manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, ...  |  read more...
USD 2,900
Digital Breast Tomosynthesis (DBT) Equipment Market: Global Industry Analysis and Opportunity Assessment, 2016 - 2026
6/28/2016 | published by: Future Market Insights
... market. In terms of value, the digital breast tomosynthesis equipment market is expected to register a CAGR of 13.9% during the forecast period. This study demonstrates market dynamics and trends in major countries and regions, ...  |  read more...
USD 5,000
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2016
6/29/2016 | published by: GlobalData
... trials scenario. This report provides top line data relating to the clinical trials on Hormone Sensitive Breast Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ...  |  read more...
USD 2,500
Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2016
6/29/2016 | published by: GlobalData
... trials scenario. This report provides top line data relating to the clinical trials on Hormone Refractory Breast Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ...  |  read more...
USD 2,500
Breast Cancer Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... metastatic setting, the overall survival remains below five years. There are today 636 companies plus partners developing 706 drugs targeting breast cancer in development. In addition, there are 7 suspended drugs and the accumulated number ...  |  read more...
USD 6,750
Target Atlas in Breast Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Breast Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Estrogen Receptor Positive (ER+) Breast Cancer - Market Insights, Epidemiology and Market Forecast-2023_United States
7/4/2016 | published by: DelveInsight
... Cancer for the United States. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Estrogen Receptor Positive (ER+) Breast Cancer from 2013-2023. According to DelveInsight, the forecasted patient population ...  |  read more...
USD 3,250
Target Atlas in Ovarian Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Ovarian Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Postpartum Hemorrhage (PPH) Treatment Devices Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
6/26/2016 | published by: Occams Business Research & Consultancy
... to contribute $769 million by 2021. Postpartum hemorrhage is defined as excessive loss of blood within first 24 hours following childbirth. This heavy loss of blood can occur in both, that is, after C-section, as ...  |  read more...
USD 3,900
Target Atlas in Endometrial Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Endometrial Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Global Intrauterine Device(IUD) Report-Market Size and Forecast 2016
7/8/2016 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Intrauterine Device(IUD) basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Bacterial Vaginosis - Pipeline Review, H2 2016
7/13/2016 | published by: Global Markets Direct
... therapeutics under development for Bacterial Vaginosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
< prev 1    3  4  5  6  7  8  9  10